Getting compounded tirzepatide involves a medical consultation, a prescription from a licensed provider, and a compounding pharmacy that fills it. The process has become more complicated since the FDA resolved the tirzepatide shortage, which changes the legal basis under which pharmacies can compound the drug. Here’s what you need to know about each step and what to watch for.
The Legal Landscape Has Shifted
Compounding pharmacies were able to produce tirzepatide copies largely because the brand-name versions (Mounjaro and Zepbound) were on the FDA’s drug shortage list. That shortage has been resolved. As of April 2026, tirzepatide does not appear on the FDA’s drug shortage list or on the list of approved bulk drug substances for outsourcing facilities.
This matters because it changes the rules. Outsourcing facilities (registered under section 503B of federal law) can only compound drugs from bulk ingredients if those ingredients appear on an approved list or the finished drug is in active shortage. Neither condition currently applies to tirzepatide. Traditional compounding pharmacies (operating under section 503A) can still fill individual prescriptions, but they’re not supposed to regularly produce what the FDA considers “essentially a copy” of a commercially available drug, meaning one with the same active ingredient, a similar strength, and the same route of administration.
There is one exception: a prescriber can document that a compounded version contains a meaningful change for a specific patient. Some providers use this pathway by prescribing tirzepatide in a different concentration, combined with another ingredient like B12, or in a formulation tailored to a patient’s needs. Whether this exception holds up long term is something the FDA is actively scrutinizing, so the availability of compounded tirzepatide could change.
Who Qualifies for a Prescription
Tirzepatide is prescribed for weight management and type 2 diabetes. The standard eligibility criteria that most providers follow are:
- BMI of 30 or higher, or
- BMI of 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes, insulin resistance, type 2 diabetes, obstructive sleep apnea, PCOS, or heart disease
You must be 18 or older. Providers will also review your medical history, family history, and prior weight loss attempts. Tirzepatide is not prescribed to people who are pregnant or breastfeeding, or those with a personal or family history of medullary thyroid carcinoma or a condition called MEN 2. A history of pancreatitis may also disqualify you.
Step 1: Get a Consultation
You have two main routes to a prescription: your primary care doctor or a telehealth weight management service. Telehealth platforms have become the more common path for compounded tirzepatide because many of them have relationships with specific compounding pharmacies and can streamline the process.
During the consultation, whether virtual or in person, your provider will assess your weight, health history, and goals. If you qualify, they’ll write a prescription specifying the dose and send it to a compounding pharmacy. Some telehealth platforms bundle the consultation fee with the medication cost, while others charge them separately. Expect the initial consultation to cost anywhere from $30 to $150 depending on the platform.
Step 2: Choose a Compounding Pharmacy
Not all compounding pharmacies are equal, and this is the step where quality matters most. Compounded drugs are not FDA-approved products. They don’t go through the same testing and manufacturing oversight as brand-name medications, so the pharmacy’s own quality controls are your main safeguard.
Look for pharmacies that hold PCAB accreditation (Pharmacy Compounding Accreditation Board, now administered by ACHC). PCAB-accredited sterile compounding pharmacies must meet the standards outlined in USP chapter 797, which governs sterile preparation quality and consistency. Since tirzepatide is an injectable, sterile compounding standards are the ones that matter for your safety. Pharmacies handling hazardous drugs must also meet additional safety requirements.
Red Flags to Avoid
The FDA has flagged concerns about compounders using salt forms of GLP-1 medications, such as semaglutide sodium or semaglutide acetate, instead of the base form used in approved drugs. While this warning specifically named semaglutide salt forms, the same principle applies to tirzepatide: the FDA has stated it lacks information on whether salt forms have the same properties as the active ingredient in approved drugs and is not aware of any lawful basis for using them in compounding. If a pharmacy is vague about what form of tirzepatide they use, ask directly, and consider it a warning sign if they can’t give a clear answer.
What It Costs
The brand-name versions of tirzepatide are expensive. Mounjaro lists at about $1,080 for a 28-day supply, and Zepbound is around $1,086. Insurance coverage varies widely, and many plans don’t cover weight management indications.
Compounded tirzepatide typically runs $250 to $500 per month, depending on your dose and the pharmacy. Lower doses (2.5 mg and 5 mg) tend to fall at the lower end of that range, while higher doses cost more because they require more of the active ingredient. Most compounding pharmacies and telehealth platforms do not accept insurance for compounded medications, so this is an out-of-pocket expense. Some platforms offer subscription pricing or multi-month discounts.
Shipping and Storage
Once your prescription is filled, most compounding pharmacies ship directly to your door. Standard processing and shipping takes roughly 48 to 72 hours, though total delivery time from order to doorstep can range from a few days to nearly two weeks depending on the pharmacy’s volume and your location.
Tirzepatide is a peptide that needs to stay cold. Pharmacies ship vials with cold packs, and the packaging should still feel cold when it arrives. If your shipment arrives warm or was left in the sun for hours, contact the pharmacy before using it. Once you have the vials at home, store them in the refrigerator.
How Dosing Works
Tirzepatide is injected once per week, typically in the abdomen, thigh, or upper arm. Compounded versions usually come in multi-dose vials rather than the pre-filled pens used for Mounjaro and Zepbound, so you’ll draw up each dose with an insulin syringe. Your provider or pharmacy should walk you through this process.
The standard titration schedule starts low and increases every four weeks:
- Weeks 1 through 4: 2.5 mg per week
- Weeks 5 through 8: 5 mg per week
- Weeks 9 through 12: 7.5 mg per week
- Weeks 13 through 16: 10 mg per week
- Weeks 17 through 20: 12.5 mg per week
- Week 21 and beyond: 15 mg per week (maximum)
Not everyone reaches 15 mg. Clinical data shows significant weight loss at 10 mg and 12.5 mg, and many people find their effective dose well before the maximum. Your provider will adjust the schedule based on how you respond and how well you tolerate each increase. The slow ramp-up exists specifically to minimize side effects.
Side Effects to Expect
Gastrointestinal symptoms are the most common side effects, and they tend to be worst during the first few weeks at each new dose level. In clinical trials, 30 to 40 percent of people experienced nausea, 20 to 25 percent had diarrhea, 15 to 18 percent dealt with vomiting, and 12 to 15 percent reported constipation. These symptoms are generally mild to moderate and improve as your body adjusts.
Eating smaller meals, avoiding greasy or heavy foods, and staying hydrated can help manage nausea during dose increases. If side effects are severe or persistent at a given dose, your provider may keep you at that level for an extra four weeks before moving up, or settle on that dose as your maintenance level.
The Bigger Picture on Risk
Compounded tirzepatide carries inherent uncertainties that brand-name versions do not. The potency of each vial depends entirely on the compounding pharmacy’s quality controls. There is no FDA batch testing, no standardized manufacturing process across pharmacies, and no guaranteed bioequivalence to the approved product. This doesn’t mean compounded tirzepatide is unsafe, but it does mean your choice of pharmacy is doing a lot of the heavy lifting on safety. Prioritize accredited pharmacies with transparent sourcing, and pay attention to how your body responds, especially if you switch between pharmacies or receive a new batch.